Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Goetz

Showing results (221-230 of 397) with videos related to

Pageof 40
Sort By:
International Journal of Oncology|June 10, 2016
Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapyJae-Hyun Park, Miran Jang, Yunus Emre Tarhan, et al.
Nature Communications|December 4, 2014
Freezing-in orientational disorder induces crossover from thermally-activated to temperature-independent transport in organic semiconductorsK P Goetz, A Fonari, D Vermeulen, et al.
Breast Cancer Research and Treatment|March 16, 2006
Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52James N Ingle, Vera J Suman, James A Mailliard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2023
Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2- breast cancer and an ESR1 mutation after disease progression on prior therapies: ELAINE 2S Damodaran, C C O'Sullivan, A Elkhanany, et al.
Clinical Breast Cancer|February 5, 2020
Case-Based Review and Clinical Guidance on the Use of Genomic Assays for Early-Stage Breast Cancer: Breast Cancer Therapy Expert Group (BCTEG)Muaiad Kittaneh, Sunil Badve, Humberto Caldera, et al.
Minerva Obstetrics and Gynecology|August 1, 2022
Salpingectomy, tubal ligation and hysteroscopic occlusion for sterilizationGreg J Marchand, Ahmed T Masoud, Alexa K King, et al.
Molecular Cancer Therapeutics|September 1, 2018
ATR Inhibition Is a Promising Radiosensitizing Strategy for Triple-Negative Breast CancerXinyi Tu, Mohamed M Kahila, Qin Zhou, et al.
Oncotarget|December 7, 2017
Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cellsMateusz Opyrchal, Malgorzata Gil, Jeffrey L Salisbury, et al.
Breast Cancer Research and Treatment|August 31, 2022
Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution studyGrace M Choong, Savannah Liddell, Roberto A Leon Ferre, et al.
Plos One|May 24, 2014
The effects of a novel hormonal breast cancer therapy, endoxifen, on the mouse skeletonAnne Gingery, Malayannan Subramaniam, Kevin S Pitel, et al.
Pageof 40

Showing results (221-230 of 397) with videos related to

Sort By:
Pageof 40
International Journal of Oncology|June 10, 2016
Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapyJae-Hyun Park, Miran Jang, Yunus Emre Tarhan, et al.
Nature Communications|December 4, 2014
Freezing-in orientational disorder induces crossover from thermally-activated to temperature-independent transport in organic semiconductorsK P Goetz, A Fonari, D Vermeulen, et al.
Breast Cancer Research and Treatment|March 16, 2006
Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52James N Ingle, Vera J Suman, James A Mailliard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2023
Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2- breast cancer and an ESR1 mutation after disease progression on prior therapies: ELAINE 2S Damodaran, C C O'Sullivan, A Elkhanany, et al.
Clinical Breast Cancer|February 5, 2020
Case-Based Review and Clinical Guidance on the Use of Genomic Assays for Early-Stage Breast Cancer: Breast Cancer Therapy Expert Group (BCTEG)Muaiad Kittaneh, Sunil Badve, Humberto Caldera, et al.
Minerva Obstetrics and Gynecology|August 1, 2022
Salpingectomy, tubal ligation and hysteroscopic occlusion for sterilizationGreg J Marchand, Ahmed T Masoud, Alexa K King, et al.
Molecular Cancer Therapeutics|September 1, 2018
ATR Inhibition Is a Promising Radiosensitizing Strategy for Triple-Negative Breast CancerXinyi Tu, Mohamed M Kahila, Qin Zhou, et al.
Oncotarget|December 7, 2017
Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cellsMateusz Opyrchal, Malgorzata Gil, Jeffrey L Salisbury, et al.
Breast Cancer Research and Treatment|August 31, 2022
Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution studyGrace M Choong, Savannah Liddell, Roberto A Leon Ferre, et al.
Plos One|May 24, 2014
The effects of a novel hormonal breast cancer therapy, endoxifen, on the mouse skeletonAnne Gingery, Malayannan Subramaniam, Kevin S Pitel, et al.
Pageof 40